Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $263.57 million. The enterprise value is $162.16 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 47.23 million shares outstanding. The number of shares has increased by 13.08% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 47.23M |
| Shares Change (YoY) | +13.08% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 34.66% |
| Owned by Institutions (%) | 38.29% |
| Float | 25.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.16 |
| Forward PS | n/a |
| PB Ratio | 2.93 |
| P/TBV Ratio | 3.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.06
| Current Ratio | 10.06 |
| Quick Ratio | 9.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.96% and return on invested capital (ROIC) is -37.96%.
| Return on Equity (ROE) | -66.96% |
| Return on Assets (ROA) | -22.25% |
| Return on Invested Capital (ROIC) | -37.96% |
| Return on Capital Employed (ROCE) | -47.74% |
| Revenue Per Employee | $234,216 |
| Profits Per Employee | -$682,121 |
| Employee Count | 116 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SLN has paid $383,000 in taxes.
| Income Tax | 383,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.50% in the last 52 weeks. The beta is 1.39, so SLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -64.50% |
| 50-Day Moving Average | 5.81 |
| 200-Day Moving Average | 6.26 |
| Relative Strength Index (RSI) | 51.41 |
| Average Volume (20 Days) | 77,155 |
Short Selling Information
| Short Interest | 814,378 |
| Short Previous Month | 923,020 |
| Short % of Shares Out | 1.72% |
| Short % of Float | 3.25% |
| Short Ratio (days to cover) | 9.44 |
Income Statement
In the last 12 months, SLN had revenue of $27.17 million and -$79.13 million in losses. Loss per share was -$1.68.
| Revenue | 27.17M |
| Gross Profit | 21.35M |
| Operating Income | -71.84M |
| Pretax Income | -52.45M |
| Net Income | -79.13M |
| EBITDA | -71.26M |
| EBIT | -71.84M |
| Loss Per Share | -$1.68 |
Full Income StatementBalance Sheet
The company has $114.16 million in cash and n/a in debt, giving a net cash position of $114.16 million or $2.42 per share.
| Cash & Cash Equivalents | 114.16M |
| Total Debt | n/a |
| Net Cash | 114.16M |
| Net Cash Per Share | $2.42 |
| Equity (Book Value) | 94.16M |
| Book Value Per Share | 1.99 |
| Working Capital | 133.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$87.18 million and capital expenditures -$178,000, giving a free cash flow of -$87.36 million.
| Operating Cash Flow | -87.18M |
| Capital Expenditures | -178,000 |
| Free Cash Flow | -87.36M |
| FCF Per Share | -$1.85 |
Full Cash Flow StatementMargins
Gross margin is 78.59%, with operating and profit margins of -264.42% and -291.24%.
| Gross Margin | 78.59% |
| Operating Margin | -264.42% |
| Pretax Margin | -289.83% |
| Profit Margin | -291.24% |
| EBITDA Margin | -262.29% |
| EBIT Margin | -264.42% |
| FCF Margin | n/a |
Dividends & Yields
SLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.08% |
| Shareholder Yield | -13.08% |
| Earnings Yield | -28.64% |
| FCF Yield | -31.62% |
Analyst Forecast
The average price target for SLN is $32.60, which is 484.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $32.60 |
| Price Target Difference | 484.23% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLN has an Altman Z-Score of -0.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.72 |
| Piotroski F-Score | 3 |
